Saturday, October 3, 2026

Nikkei 225 Went Up By Over 5% In The Last 21 Sessions

Nikkei 225 Went Up By Over 5% In The Last 21 Sessions

(VIANEWS) - Nikkei 225 (N225) has been up by 5.64% for the last 21 sessions. At 21:08 EST on Thursday, 4 July, Nikkei 225 (N225) is $40,888.09.

About Nikkei 225's yearly highs and lows, it's 34.11% up from its 52-week low and 0.52% down from its 52-week high.

Volatility

Nikkei 225's last week, last month's, and last quarter's current intraday variation average was 0.83%, 0.30%, and 0.81%, respectively.

Nikkei 225's highest amplitude of average volatility was 0.83% (last week), 0.65% (last month), and 0.81% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nikkei 225's is considered to be oversold (<=20).

News about

  • According to Zacks on Wednesday, 3 July, "Validating its fundamental strength, UBER was added to the much sought-after S&P 500 index in December last year. ", "With a portfolio of 500 leading companies that have approximately 80% coverage of the available market capitalization, the S&P 500 is widely regarded as the best single measure of large-cap U.S. equities."
  • According to Zacks on Wednesday, 3 July, "The tech-heavy Nasdaq Composite Index outperformed, rising 6%, while the S&P 500 and the Dow Jones gained 3.5% and 1.1%, respectively, last month.", "In fact, the S&P 500 topped the 5,500 level after hitting the 5,400 mark earlier in June. "
  • According to Zacks on Wednesday, 3 July, "We were mixed ahead of a slew of economic data - more about this below - but are now -20 points on the Dow, -7 on the S&P 500 and -33 points on the Nasdaq at this hour. "
  • According to Business Insider on Wednesday, 3 July, "As of 7.55 am ET, the Dow futures were up 29.00 points, the S&P 500 futures were declining 2.00 points and the Nasdaq 100 futures were sliding 14.50 points.", "The S&P 500 settled at 5,509.01, gaining 33.92 points or 0.62%, while the Nasdaq advanced 149.46 points or 0.84 percent, to 18,028.76."
  • According to FXStreet on Wednesday, 3 July, "The S&P 500 and the NASDAQ both witnessed new all-time highs in Wednesday's shortened session after the ADP Employment Change report showed fewer new jobs in the US economy than expected. "

More news about Nikkei 225 (N225).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com